AVANDAMET Compared to Metformin Evaluation Trial (ACME): A 48-week Randomized, Open-label, Multicenter Study to Compare the Efficacy and Tolerability of AVANDAMET to Metformin Monotherapy in Subjects With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Control on Submaximal Metformin.
AVANDAMET Compared to Metformin Evaluation Trial (ACME): A 48-week Randomized, Open-label, Multicenter Study to Compare the Efficacy and Tolerability of AVANDAMET to Metformin Monotherapy in Subjects With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Control on Submaximal Metformin.
This 48-week study will compare AVANDAMET vs. Metformin monotherapy for blood glucose control in patients with Type 2 Diabetes Mellitus.
Inclusion Criteria:
Exclusion Criteria:
Houston, New Brunswick E6E 1H1, Canada
North York, Ontario M3M 3E5, Canada
Courcelette, Quebec G0A 1R1, Canada
Lle Perrot, Quebec H8Y 3J2, Canada
Sainte-Henri de Levis, Quebec G0R 3E0, Canada
Vaudreuil, Quebec J7V 8P9, Canada
Ville Lasalle, Quebec H8N 1X9, Canada